• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Celebrities and Cancer
  • Cancer Types
  • Radiotherapy
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Immune Oncology
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Yvonne Award 2025
Jan / 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Dec    
OncodailyJournal CancerWorld OncoDaily IO OncoDaily GI Hemostasis Today Fertility News
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

100 Most Influential CEOs

"Peace is the Best Medicine" - WHO Director-General Announces What Healthcare is Missing

Tedros Adhanom Ghebreyesus, Director-General

TWINPEAK study: Spevatamig Plus Gemcitabine and Nab-Paclitaxel as 1L Therapy in CLDN18.2 Positive mPDAC

TWINPEAK study

Gevorg Tamamyan: Just Get Things Done

Gevorg Tamamyan

Highlights from ASCO GI 2026 by Wafik El-Deiry

ASCO GI 2026

CheckMate 9DW at ASCO GI 2026: Nivolumab plus ipilimumab vs lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma

CheckMate 9DW

Dual Checkpoint Blockade in Refractory Anal Squamous Cell Carcinoma

Anal Squamous Cell Carcinoma

CRITICS-II Trial at ASCO GI: Total Neoadjuvant Therapy in Resectable Gastric Cancer

CRITICS-II Trial

OncoCalendar

4 events found.

European School of Haematology

« All Events
Phone + 33(0)1 57 27 67 39
Email info(at)esh.org
Website https://www.esh.org/

Events from this organizer

Today
  • November 2024

  • Fri 15
    ESH-EBMT-EHA-IPIG 3rd Translational Research Conference
    Nov 15, 2024 • 12:00 AM - Nov 17, 2024 • 12:00 AM

    ESH-EBMT-EHA-IPIG 3rd Translational Research Conference

    Espace Saint-Martin 199 Bis r St Martin, 75003 Paris, Paris, Sweden

    The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference on Bone Marrow Failure and Leukaemia Predisposition Syndromes will be held at Paris, France from November 15-17, 2024. It will offer valuable insights for both clinical and non-clinical scientists, including M.D.s and Ph.D.s of all levels, who are interested in the biology, pathophysiology, diagnosis, and treatment of bone marrow […]

  • March 2025

  • Fri 7
    4th How to Diagnose and Treat: CML/MPN
    Mar 7, 2025 • 9:00 AM - Mar 9, 2025 • 2:00 PM

    4th How to Diagnose and Treat: CML/MPN by ESH

    Austria Trend Hotel Savoyen Rennweg 16, Vienna, Austria

    4th How to Diagnose and Treat: CML/MPN will be held at Vienna, Austria from March 7-9, 2025. ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management. They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to increase […]

  • April 2025

  • Thu 3
    5th How to Diagnose and Treat: Multiple Myeloma
    Apr 3, 2025 • 12:00 AM - Apr 5, 2025 • 12:00 AM

    5th How to Diagnose and Treat: Multiple Myeloma by ESH

    Austria Trend Hotel Savoyen Rennweg 16, Vienna, Austria

    5th How to Diagnose and Treat: Multiple Myeloma will be held at Vienna Austria from April 3-5, 2025. ESH How to Diagnose and Treat meetings are disease-specific meetings that address state-of-the-art diagnostic and clinical management. They are based on the presentation and analysis of real clinical cases. Voting technology is used as a self-evaluation tool and to […]

  • May 2025

  • Thu 22
    4th Translational Research Conference: Acute Lymphoblastic Leukaemia
    May 22, 2025 • 12:00 AM - May 24, 2025 • 12:00 AM

    4th Translational Research Conference: Acute Lymphoblastic Leukaemia by ESH

    Grand Hotel Malahide Coast Road Malahide Dublin, Dublin, Ireland

    4th Translational Research Conference: Acute Lymphoblastic Leukaemia will be held at Malahide (Dublin), Ireland from May 22-24, 2025. ESH Translational Research Conference programs are tailored to highlight the latest advancements in basic, clinical, and therapeutic research, with a focus on future developments in the field. These conferences are structured to provide extensive opportunities for in-depth […]

  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

LinkedIn X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat
Oncology OncoDaily cancer fight against cancer Global fight against cancer Breast Cancer cancer care ASCO Lung cancer Cancer research ESMO Headlines MD Anderson Cancer Center immunotherapy NSCLC cancer awareness cancer treatment Research ASCO24 colorectal cancer Childhood Cancer prostate cancer AACR clinical trials FDA UICC Dana-Farber Cancer Institute European Cancer Organisation American Cancer Society SIOP NCI chemotherapy Myeloma National Cancer Institute Robert Orlowski American Society of Clinical Oncology Vivek Subbiah healthcare Myeloma Paper of the Day Paolo Tarantino AI Pancreatic Cancer IASLC ASCO25 radiation oncology WHO multiple myeloma cervical cancer Memorial Sloan Kettering Cancer Center Zainab Shinkafi-Bagudu

European School of Oncology

Sitemap

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}